← Back to Search

Anti-metabolites

BST-236 for Acute Myeloid Leukemia (ELPIS Trial)

Phase 2
Waitlist Available
Research Sponsored by BioSight Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 28-35 of induction/re induction course
Awards & highlights

ELPIS Trial Summary

This trial will test a new cancer drug, BST-236, on patients with newly diagnosed AML who are too old or sick for standard chemotherapy. The goal is to see if BST-236 is more effective than what has been seen in similar patients in the past.

Eligible Conditions
  • Acute Myeloid Leukemia

ELPIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 28-35 of induction/re induction course
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 28-35 of induction/re induction course for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Complete Remission

ELPIS Trial Design

1Treatment groups
Experimental Treatment
Group I: BST-236Experimental Treatment1 Intervention
BST-236 Intravenous, 4.5 g/m2/d or 2.5 g/m2/d, for 6 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BST-236
2018
Completed Phase 2
~70

Find a Location

Who is running the clinical trial?

BioSight Ltd.Lead Sponsor
3 Previous Clinical Trials
140 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
2018. "Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03435848.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top